Clinical trial

Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

NCT02204163

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Eutropin Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Genotropin Normalized identity: GenotropinView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-06-01

PhasePHASE3

Conditions

Prader-Willi Syndromeverified · MONDO: Prader-Willi syndrome

Interventions

EutropinDRUG

GenotropinDRUG · verified · RxNorm: Genotropin

Sponsors & collaborators

LG Life Scienceslead sponsor

Mapped research locations

SeoulSouth Korea2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02204163 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.